ORCHARD THERAPEUTICS PLC's ticker is ORTX and the CUSIP is 68570P101. A total of 48 filers reported holding ORCHARD THERAPEUTICS PLC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $851,562 | -26.0% | 2,295,315 | -0.3% | 0.00% | – |
| Q3 2022 | $1,151,000 | +5131.8% | 2,301,742 | +6119.4% | 0.00% | – |
| Q2 2022 | $22,000 | -81.0% | 37,009 | -77.2% | 0.00% | – |
| Q1 2022 | $116,000 | -59.6% | 162,207 | -25.5% | 0.00% | – |
| Q4 2021 | $287,000 | -55.9% | 217,839 | -23.1% | 0.00% | – |
| Q3 2021 | $651,000 | -50.6% | 283,165 | -5.8% | 0.00% | – |
| Q2 2021 | $1,319,000 | -53.3% | 300,609 | -22.8% | 0.00% | -100.0% |
| Q1 2021 | $2,827,000 | +731.5% | 389,482 | +395.3% | 0.00% | – |
| Q4 2020 | $340,000 | +85.8% | 78,630 | +76.4% | 0.00% | – |
| Q3 2020 | $183,000 | -97.7% | 44,579 | -96.7% | 0.00% | -100.0% |
| Q2 2020 | $8,118,000 | +24.6% | 1,353,114 | +56.4% | 0.00% | 0.0% |
| Q1 2020 | $6,514,000 | -6.4% | 865,045 | +71.0% | 0.00% | 0.0% |
| Q4 2019 | $6,956,000 | -9.3% | 505,877 | -21.7% | 0.00% | -25.0% |
| Q3 2019 | $7,673,000 | – | 645,860 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 2,962,267 | $22,306,000 | 52.57% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 8,862,247 | $66,733,000 | 2.12% |
| RA Capital Management | 10,364,658 | $57,048,000 | 1.80% |
| Vivo Capital, LLC | 1,627,225 | $12,253,000 | 1.11% |
| Casdin Capital, LLC | 975,000 | $7,342,000 | 0.78% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1,440,744 | $10,849,000 | 0.36% |
| Ghost Tree Capital, LLC | 178,109 | $1,341,000 | 0.36% |
| Woodline Partners LP | 591,250 | $4,452,000 | 0.32% |
| Bleichroeder LP | 125,200 | $943,000 | 0.25% |
| ArrowMark Colorado Holdings LLC | 1,488,314 | $11,207,000 | 0.15% |